Samsung Bioepis Enters into Partnership Agreement with Sandoz for Up to Five Next-Generation Biosimilar Candidates


Under the terms of the agreement, Samsung Bioepis will be responsible for development, regulatory registration in key markets, and manufacture of the biosimilars, while Sandoz will be responsible for commercialization in global markets, excluding China, Hong Kong, Taiwan, Macau, and Republic of Korea.



Source link

  • Related Posts

    Israel says it killed another Iranian leader, but that doesn’t mean it’s winning the war

    Though plenty of experts warned that Iran could and would likely close the strait if attacked, this crisis seems to have come as a surprise to those prosecuting the war.…

    Cority Connect 2026: Cority Showcases the AI-Driven Future of EHS+

    Cority helps customers see and prevent risks across their operations in real time. Our EHS+ platform converges people, data, and AI agents to provide a clear view of information people…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Israel says it killed another Iranian leader, but that doesn’t mean it’s winning the war

    Israel says it killed another Iranian leader, but that doesn’t mean it’s winning the war

    Temporary bleachers are being built at BMO Field for the FIFA World Cup. Are they safe?

    Temporary bleachers are being built at BMO Field for the FIFA World Cup. Are they safe?

    Transfer rumors, news: Liverpool, Man Utd want Wolves’ Gomes

    Transfer rumors, news: Liverpool, Man Utd want Wolves’ Gomes

    UK fights to keep selling more potent cannabis products in EU ‘reset’ talks

    Meet Vurt, the mobile-first streaming platform for indie filmmakers embracing vertical video

    Meet Vurt, the mobile-first streaming platform for indie filmmakers embracing vertical video

    Saskatchewan to deliver deficit budget, promises to ‘protect’ public services

    Saskatchewan to deliver deficit budget, promises to ‘protect’ public services